Drug Search Results
More Filters [+]

Ropocamptide

Alternative Names: ropocamptide, ll-37, ll37, ll 37
Latest Update: 2024-05-13
Latest Update Note: PubMed Publication

Product Description

Mechanisms of Action: Unknown

Novel Mechanism: No

Modality: Large Molecule

Route of Administration: Topical

FDA Designation: None *

Approval Status: Not Approved

Approved Countries: None

Approved Indications: None

Known Adverse Events: None

Company: Lipopeptide AB
Company Location:
Company CEO:
Additonal Commercial Interests: None

Clinical Description

Map of Global Clinical Trials for Ropocamptide

Countries in Clinic:

Active Clinical Trial Count:

Highest Development Phases

Phase 2: Leg Ulcer|Diabetic Foot|Inflammation|Melanoma

Trial

Phase

Trial Status

Disease

Primary Completion Date

Probability of Success

ChiCTR2300067840

N/A

Recruiting

COVID-19

2026-12-31

ChiCTR2200063622

N/A

Recruiting

Coronavirus Infections|Pneumonia

2022-09-30

ChiCTR2000029120

N/A

Not yet recruiting

Unknown

2021-02-01

ChiCTR2000029139

N/A

Not yet recruiting

Unknown

2021-02-01

Recent News Events